Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon

Digestive Diseases and Sciences

Volumn 43, Issue 8, 1998, Pages 1641-1645

  Gasbarrini, Antonio ^a   Massari, Irene ^a   Serricchio, Michele ^a   Tondi, Paolo ^a   De Luca, Annetta ^a   Franceschi, Francesco ^a   Ojetti, Veronica ^a   Lago, Antonio Dal ^a   Flore, Roberto ^a   Santoliquido, Angelo ^a   Gasbarrini, Giovanni ^a   Pola, Paolo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

H. pylori; Raynaud's phenomenon; Urea breath test; Vasospasm

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE;

ADULT; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME; VASOSPASM;

EID: 15644381410     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018842527111     Document Type: Article

References (28)

1. Calam J: Helicobacter pylori. Eur 3 Clin Invest 24:501-510, 1994
2. Gasbarrini G, Pretolani S, Bonvicini F, Gatto MRA, Tonelli E, Megraud F, et al: A population based study of Helicobacter pylori infection in a European country: The San Marino Study. Relations with gastrointestinal diseases. Gut 36:838-844, 1995
3. Gasbarrini A, Franceschi F, Gasbarrini G, Pola P: Extraintestinal pathology associated with Helicobacter infection. Eur J Gast Hepatol 9:231-233, 1997
4. Mendall MA, Patel P, Carrington D, Strachan D, Leatham E, Molineaux N, Levy J, Blackstone C, Saymour CA, Camm AJ, Northfield TC: Association of Helicobacter pylori and Chlamydia pneumoniae infection with coronary heart disease and cardiovascular risk factors. Br Med J 311:711-714, 1995
5. Morgando A, Sanseverino P, Perotto C, Molino F, Gai V, Ponzetto A: Helicobacter pylori seropositivity in myocardial infarction. Lancet 345:1380, 1995
6. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437-439, 1994
7. Miragliotta G, Del Prete R, Mosca A: Helicobacter pylori infection and coronary heart disease. Lancet 344:751, 1994
8. Gasbarrini A, Serricchio M, Tondi P, Gasbarrini G, Pola P: Association of Helicobacter pylori infection with Raynaud phenomenon. Lancet 348:966-967, 1996
9. Crabtree JE: Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastrenterol 31(suppl) 215:3-10, 1996
10. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JL: Mucosal tumor necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 31:1473-1477, 1991
11. Maseri A, Biasucci LM, Liuzzo G: Inflammation in ischaemic heart disease. Br Med J 312:1049-1050, 1996
12. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC: C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study. Br Med J 312:1061-1065, 1996
13. Yoshida N, Granger DN, Evans DJ, Graham DY, Anderson DC: Mechanism involved in Helicobacter pylori-induced inflammation. Gastroenterology 105:1431-1440, 1993
14. Kurose I, Granger DN, Evans DJ, Evans DG, Graham DY, Myiaska M, Anderson DC: Helicobacter pylori-induced microvacular protein leakage in rats: Role of neutrophils, mast cells and platelets. Gastroenterology 107:70-79, 1994
15. Lancon B, Pistorius MA, Beurier P, De Faucal P: Primary Raynaud's phenomenon. Age of onset and pathogenesis in prospective study of 424 patients. Angiology 45:677-686, 1994
16. Pistorius MA, Planchon B, De Faucal P: Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Int Angiol 13:10-13, 1944
17. Wigley FM, Wise RA, Seibold JR, McCloskey DA, Kujala G, Medsger TA Jr, et al: Intravenous Iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A muticenter, placebo-controlled, double-blind study. Ann Intern Med 120:199-206, 1994
18. 13C urea breath test. In Helicobacter pylori: Technique for Clinical Diagnosis and Basic Research. A Lee, F Megraud (eds). London, Saunders 1996, pp 74-81
19. Lanza FL: Endoscopie studies of gastric and duodenal injury after the use of ibuprofen, aspirin and other non steroidal anti-inflammatory agents. Am J Med 77:19-24, 1984
20. Zhang QB, Nakshabendi IM, Mokhashi MS, Dawodu JB, Gemmel CG, Russel RI: Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 38:841-884, 1996
21. Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, et al: Role of chemokines in gastric mucosa with Helicobacter pylori infection. Gut 39(suppl):A60, 1996
22. De Koster E: Microbiological aspects of Helicobacter pylori. Eur J Gastroenerol Hepatol 5:S33-S35, 1993
23. 4 generation associated with H. pylori colonization. Prostaglandins 44:75-86, 1992
24. Bierti L, Cernuschi C, Abbiati C, Beccari G, Di Battista R, Marchi R, et al: Correlation between gastric infection with Helicobacter pylori and plasma levels of fibrinogen, plasminogen activator inhibitor (PAI), and von Willebrand factor (vWF) antigen. Gut 39(suppl):A90, 1996 (abstract)
25. Parente F, Imbesi V, Maconi G, Rossi E, Bianchi Porro G: Is Helicobacter pylori (HP) infection associated with a tendency towards a procoagulant state in healthy individuals? Gut 39:A93, 1996 (abstract)
26. Nieminen MS, Mattila K and Valtonen V: Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 14(suppl):12-16, 1993
27. Negrini R, Savio A, Poiesi C, Appelmelk BJ, Buffoli F, Paterlini A, et al: Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111:655-665, 1996
28. Fujiwara Y, Yamanaka O, Nakamura T, Yamaguchi H: Coronary spasm in two sisters. Jpn Circ J 57:472-474, 1993